Selecxine

About:

Selecxine is a biopharmaceutical development company specialized in the field of immunotherapeutics.

Top Investors: IMM Investment, Stonebridge Capital, UTC Investment Co., Hi Investment Partners, STIC Ventures

Description:

Selecxine is a biopharmaceutical development company specialized in the field of immunotherapeutics. Selecxine strives to develop immunotherapeutics a new paradigm of pharmaceuticals– through a specialized antibody development process, using an innovative platform technology of functional antibody screening and development.

Total Funding Amount:

33B KRW

Headquarters Location:

Songpadong, Seoul-t'ukpyolsi, South Korea

Founded Date:

2018-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2022-03-29

IPO Status:

Private

Industries: